This also may have implications for pharmacological treatments for hypertension (Angiotensin-Converting Enzyme Inhibitors-ACES, Angiotensin Receptor Blockers-ARBS) in the pediatric CKD population with G diagnoses. This evidence concerns the gene ACE and Hypertension.